STOCK TITAN

Freightos (CRGO) chief strategy officer granted 4,000 performance-based shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freightos Ltd Chief Strategy Officer Ian Arroyo received 4,000 ordinary shares of CRGO as a share grant tied to performance criteria under previously awarded performance share units. The grant carried a price of $0.00 per share and increased his directly held ordinary shares to 25,141.

The other rows mainly update existing holdings, including multiple blocks of ordinary shares underlying restricted share units that vest over schedules running through July 15, 2029. Arroyo also holds stock options over 228,674, 12,314, and 49,473 ordinary shares at exercise prices of $4.17 and $1.07 per share with expirations between 2030 and 2032.

Positive

  • None.

Negative

  • None.
Insider Arroyo Ian
Role Chief Strategy Officer
Type Security Shares Price Value
Grant/Award Ordinary Shares 4,000 $0.00 --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Ordinary Shares — 25,141 shares (Direct, null); Stock Option (right to buy) — 49,473 shares (Direct, null)
Footnotes (1)
  1. The transaction reported in this row consists of the grant of ordinary shares to the Reporting Person by the wholly-independent compensation committee of the board of directors of the Issuer upon the Reporting Person's achievement of performance criteria under performance share units (PSUs) previously granted by the Issuer to the Reporting Person. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 7,000 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over three calendar quarters (33.33% per quarter) such that all such 7,000 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2026. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 21,500 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over seven calendar quarters (approximately 14.286% per quarter) such that all such 21,500 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2027. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on July 15, 2026. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on July 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vest upon the one-year anniversary of the vesting commencement date, and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
Share grant 4,000 shares Ordinary shares granted at $0.00 per share
Shares after grant 25,141 shares Direct ordinary shares following the 4,000-share grant
Stock option 1 228,674 shares at $4.17 Option over ordinary shares, expiring February 17, 2032
Stock option 2 12,314 shares at $4.17 Option over ordinary shares, expiring July 19, 2031
Stock option 3 49,473 shares at $1.07 Option over ordinary shares, expiring December 16, 2030
Unknown-code entries 11 holdings rows Reported as informational only; no transactions effected
performance share units (PSUs) financial
"grant of ordinary shares ... upon the Reporting Person's achievement of performance criteria under performance share units (PSUs)"
restricted share units ("RSUs") financial
"ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted"
stock option (right to buy) financial
"security_title": "Stock Option (right to buy)""
vesting commencement date financial
"RSUs granted ... that began vesting on July 1, 2025 and that vest ... from the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Arroyo Ian

(Last)(First)(Middle)
C/O FREIGHTOS LIMITED, PLANTA 10, AVDA.
DIAGONAL, 211

(Street)
BARCELONA08018

(City)(State)(Zip)

SPAIN

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Strategy Officer
2a. Foreign Trading Symbol
[N/A]
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares06/10/2026A(1)4,000A$025,141D
Ordinary Shares(2)6,244(3)D
Ordinary Shares(2)20,505(4)D
Ordinary Shares(2)37,500(5)D
Ordinary Shares(2)37,500(6)D
Ordinary Shares(2)36,000(7)D
Ordinary Shares(2)38,000(8)D
Ordinary Shares(2)38,000(9)D
Ordinary Shares(2)54,600(10)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)(2)$1.0712/01/202412/16/2030Ordinary Shares49,47349,473D
Stock Option (right to buy)(2)$4.1707/01/202507/19/2031Ordinary Shares12,31412,314D
Stock Option (right to buy)(2)$4.1701/01/202602/17/2032Ordinary Shares228,674228,674D
Explanation of Responses:
1. The transaction reported in this row consists of the grant of ordinary shares to the Reporting Person by the wholly-independent compensation committee of the board of directors of the Issuer upon the Reporting Person's achievement of performance criteria under performance share units (PSUs) previously granted by the Issuer to the Reporting Person.
2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
3. The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 7,000 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over three calendar quarters (33.33% per quarter) such that all such 7,000 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2026.
4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 21,500 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over seven calendar quarters (approximately 14.286% per quarter) such that all such 21,500 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2027.
5. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.
6. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on July 15, 2026.
7. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on July 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vest upon the one-year anniversary of the vesting commencement date, and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.
8. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.
9. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.
10. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Max Sitnick, Attorney-in-fact06/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Freightos (CRGO) executive Ian Arroyo report in this Form 4?

Ian Arroyo reported a grant of 4,000 Freightos ordinary shares as compensation. These shares were awarded upon meeting performance criteria under previously granted performance share units, increasing his directly held ordinary shares to 25,141 while leaving his option and RSU schedules unchanged.

How many Freightos (CRGO) shares did Ian Arroyo acquire in this insider filing?

He acquired 4,000 ordinary shares of Freightos. The shares were granted at a price of $0.00 per share as a compensation award, linked to performance share units. Following the grant, his direct ordinary share holdings reported in this row rose to 25,141 shares.

Are the other entries in Ian Arroyo’s Freightos (CRGO) Form 4 new trades?

No, a footnote explains there were no transactions in those rows. Those entries are included for informational purposes only, mainly showing existing holdings of ordinary shares and restricted share units with various vesting schedules extending through 2029.

What stock options does Ian Arroyo hold in Freightos (CRGO)?

He holds stock options over 228,674 and 12,314 ordinary shares at a $4.17 exercise price and 49,473 shares at $1.07. These options expire between December 2030 and February 2032 and reflect potential future share acquisitions if exercised.

What RSU vesting schedules are disclosed for Freightos (CRGO) executive Ian Arroyo?

The filing describes multiple RSU grants that vest quarterly or cliff-vest, with start dates in 2025 and 2026. Vesting runs through dates including July 15, 2026, July 15, 2027, December 30, 2026, December 30, 2027, December 31, 2027, and April 1, 2029.